These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

715 related items for PubMed ID: 27538418

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric Signs.
    Maillet A, Météreau E, Tremblay L, Favre E, Klinger H, Lhommée E, Le Bars D, Castrioto A, Prange S, Sgambato V, Broussolle E, Krack P, Thobois S.
    Mov Disord; 2021 Dec; 36(12):2888-2900. PubMed ID: 34494685
    [Abstract] [Full Text] [Related]

  • 3. Imaging the Etiology of Apathy, Anxiety, and Depression in Parkinson's Disease: Implication for Treatment.
    Thobois S, Prange S, Sgambato-Faure V, Tremblay L, Broussolle E.
    Curr Neurol Neurosci Rep; 2017 Aug 18; 17(10):76. PubMed ID: 28822071
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease.
    Ballanger B, Klinger H, Eche J, Lerond J, Vallet AE, Le Bars D, Tremblay L, Sgambato-Faure V, Broussolle E, Thobois S.
    Mov Disord; 2012 Jan 18; 27(1):84-9. PubMed ID: 21994070
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease.
    Picillo M, Santangelo G, Erro R, Cozzolino A, Amboni M, Vitale C, Barone P, Pellecchia MT.
    Parkinsonism Relat Disord; 2017 Apr 18; 37():106-110. PubMed ID: 28214265
    [Abstract] [Full Text] [Related]

  • 15. Precuneus degeneration and isolated apathy in patients with Parkinson's disease.
    Shin JH, Shin SA, Lee JY, Nam H, Lim JS, Kim YK.
    Neurosci Lett; 2017 Jul 13; 653():250-257. PubMed ID: 28579482
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
    Wile DJ, Agarwal PA, Schulzer M, Mak E, Dinelle K, Shahinfard E, Vafai N, Hasegawa K, Zhang J, McKenzie J, Neilson N, Strongosky A, Uitti RJ, Guttman M, Zabetian CP, Ding YS, Adam M, Aasly J, Wszolek ZK, Farrer M, Sossi V, Stoessl AJ.
    Lancet Neurol; 2017 May 13; 16(5):351-359. PubMed ID: 28336296
    [Abstract] [Full Text] [Related]

  • 20. Monoaminergic Degeneration and Ocular Motor Abnormalities in De Novo Parkinson's Disease.
    Woo KA, Joun JH, Yoon EJ, Lee CY, Jeon B, Kim YK, Lee JY.
    Mov Disord; 2023 Dec 13; 38(12):2291-2301. PubMed ID: 37846885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.